Global Dog Vaccines Market Growth 2025-2031
The global Dog Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for dogs
United States market for Dog Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Dog Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Dog Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Dog Vaccines players cover Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Dog Vaccines Industry Forecast” looks at past sales and reviews total world Dog Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Dog Vaccines sales for 2025 through 2031. With Dog Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dog Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Dog Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dog Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dog Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dog Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dog Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Dog Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Dog Vaccines market?
What factors are driving Dog Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dog Vaccines market opportunities vary by end market size?
How does Dog Vaccines break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for dogs
United States market for Dog Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Dog Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Dog Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Dog Vaccines players cover Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Dog Vaccines Industry Forecast” looks at past sales and reviews total world Dog Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Dog Vaccines sales for 2025 through 2031. With Dog Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dog Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Dog Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dog Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dog Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dog Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dog Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Dog Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Below 6 Months
- Above Months
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer Healthcare
- Vetoquinol S.A
- Boehringer Ingelheim
- Ceva
- Eli Lilly
- Heska Co.
- Merck Animal Health
- Merial (Sanofi)
- Virbac
- Zoetis (Pfizer)
What is the 10-year outlook for the global Dog Vaccines market?
What factors are driving Dog Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dog Vaccines market opportunities vary by end market size?
How does Dog Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dog Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Dog Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Dog Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Dog Vaccines Segment by Type
2.2.1 Attenuated Live Vaccines
2.2.2 Conjugate Vaccines
2.2.3 Inactivated Vaccines
2.2.4 Subunit Vaccines
2.2.5 Toxoid Vaccines
2.2.6 DNA Vaccines
2.2.7 Recombinant Vaccines
2.3 Dog Vaccines Sales by Type
2.3.1 Global Dog Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Dog Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Dog Vaccines Sale Price by Type (2020-2025)
2.4 Dog Vaccines Segment by Application
2.4.1 Below 6 Months
2.4.2 Above Months
2.5 Dog Vaccines Sales by Application
2.5.1 Global Dog Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Dog Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Dog Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Dog Vaccines Breakdown Data by Company
3.1.1 Global Dog Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Dog Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Dog Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Dog Vaccines Revenue by Company (2020-2025)
3.2.2 Global Dog Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Dog Vaccines Sale Price by Company
3.4 Key Manufacturers Dog Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dog Vaccines Product Location Distribution
3.4.2 Players Dog Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DOG VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Dog Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Dog Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Dog Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Dog Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Dog Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Dog Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Dog Vaccines Sales Growth
4.4 APAC Dog Vaccines Sales Growth
4.5 Europe Dog Vaccines Sales Growth
4.6 Middle East & Africa Dog Vaccines Sales Growth
5 AMERICAS
5.1 Americas Dog Vaccines Sales by Country
5.1.1 Americas Dog Vaccines Sales by Country (2020-2025)
5.1.2 Americas Dog Vaccines Revenue by Country (2020-2025)
5.2 Americas Dog Vaccines Sales by Type (2020-2025)
5.3 Americas Dog Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dog Vaccines Sales by Region
6.1.1 APAC Dog Vaccines Sales by Region (2020-2025)
6.1.2 APAC Dog Vaccines Revenue by Region (2020-2025)
6.2 APAC Dog Vaccines Sales by Type (2020-2025)
6.3 APAC Dog Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Dog Vaccines by Country
7.1.1 Europe Dog Vaccines Sales by Country (2020-2025)
7.1.2 Europe Dog Vaccines Revenue by Country (2020-2025)
7.2 Europe Dog Vaccines Sales by Type (2020-2025)
7.3 Europe Dog Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dog Vaccines by Country
8.1.1 Middle East & Africa Dog Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Dog Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Dog Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Dog Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dog Vaccines
10.3 Manufacturing Process Analysis of Dog Vaccines
10.4 Industry Chain Structure of Dog Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dog Vaccines Distributors
11.3 Dog Vaccines Customer
12 WORLD FORECAST REVIEW FOR DOG VACCINES BY GEOGRAPHIC REGION
12.1 Global Dog Vaccines Market Size Forecast by Region
12.1.1 Global Dog Vaccines Forecast by Region (2026-2031)
12.1.2 Global Dog Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Dog Vaccines Forecast by Type (2026-2031)
12.7 Global Dog Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer Healthcare
13.1.1 Bayer Healthcare Company Information
13.1.2 Bayer Healthcare Dog Vaccines Product Portfolios and Specifications
13.1.3 Bayer Healthcare Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer Healthcare Main Business Overview
13.1.5 Bayer Healthcare Latest Developments
13.2 Vetoquinol S.A
13.2.1 Vetoquinol S.A Company Information
13.2.2 Vetoquinol S.A Dog Vaccines Product Portfolios and Specifications
13.2.3 Vetoquinol S.A Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Vetoquinol S.A Main Business Overview
13.2.5 Vetoquinol S.A Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Dog Vaccines Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Dog Vaccines Product Portfolios and Specifications
13.4.3 Ceva Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 Eli Lilly
13.5.1 Eli Lilly Company Information
13.5.2 Eli Lilly Dog Vaccines Product Portfolios and Specifications
13.5.3 Eli Lilly Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Eli Lilly Main Business Overview
13.5.5 Eli Lilly Latest Developments
13.6 Heska Co.
13.6.1 Heska Co. Company Information
13.6.2 Heska Co. Dog Vaccines Product Portfolios and Specifications
13.6.3 Heska Co. Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Heska Co. Main Business Overview
13.6.5 Heska Co. Latest Developments
13.7 Merck Animal Health
13.7.1 Merck Animal Health Company Information
13.7.2 Merck Animal Health Dog Vaccines Product Portfolios and Specifications
13.7.3 Merck Animal Health Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Merck Animal Health Main Business Overview
13.7.5 Merck Animal Health Latest Developments
13.8 Merial (Sanofi)
13.8.1 Merial (Sanofi) Company Information
13.8.2 Merial (Sanofi) Dog Vaccines Product Portfolios and Specifications
13.8.3 Merial (Sanofi) Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Merial (Sanofi) Main Business Overview
13.8.5 Merial (Sanofi) Latest Developments
13.9 Virbac
13.9.1 Virbac Company Information
13.9.2 Virbac Dog Vaccines Product Portfolios and Specifications
13.9.3 Virbac Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Virbac Main Business Overview
13.9.5 Virbac Latest Developments
13.10 Zoetis (Pfizer)
13.10.1 Zoetis (Pfizer) Company Information
13.10.2 Zoetis (Pfizer) Dog Vaccines Product Portfolios and Specifications
13.10.3 Zoetis (Pfizer) Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Zoetis (Pfizer) Main Business Overview
13.10.5 Zoetis (Pfizer) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dog Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Dog Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Dog Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Dog Vaccines Segment by Type
2.2.1 Attenuated Live Vaccines
2.2.2 Conjugate Vaccines
2.2.3 Inactivated Vaccines
2.2.4 Subunit Vaccines
2.2.5 Toxoid Vaccines
2.2.6 DNA Vaccines
2.2.7 Recombinant Vaccines
2.3 Dog Vaccines Sales by Type
2.3.1 Global Dog Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Dog Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Dog Vaccines Sale Price by Type (2020-2025)
2.4 Dog Vaccines Segment by Application
2.4.1 Below 6 Months
2.4.2 Above Months
2.5 Dog Vaccines Sales by Application
2.5.1 Global Dog Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Dog Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Dog Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Dog Vaccines Breakdown Data by Company
3.1.1 Global Dog Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Dog Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Dog Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Dog Vaccines Revenue by Company (2020-2025)
3.2.2 Global Dog Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Dog Vaccines Sale Price by Company
3.4 Key Manufacturers Dog Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dog Vaccines Product Location Distribution
3.4.2 Players Dog Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DOG VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Dog Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Dog Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Dog Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Dog Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Dog Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Dog Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Dog Vaccines Sales Growth
4.4 APAC Dog Vaccines Sales Growth
4.5 Europe Dog Vaccines Sales Growth
4.6 Middle East & Africa Dog Vaccines Sales Growth
5 AMERICAS
5.1 Americas Dog Vaccines Sales by Country
5.1.1 Americas Dog Vaccines Sales by Country (2020-2025)
5.1.2 Americas Dog Vaccines Revenue by Country (2020-2025)
5.2 Americas Dog Vaccines Sales by Type (2020-2025)
5.3 Americas Dog Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dog Vaccines Sales by Region
6.1.1 APAC Dog Vaccines Sales by Region (2020-2025)
6.1.2 APAC Dog Vaccines Revenue by Region (2020-2025)
6.2 APAC Dog Vaccines Sales by Type (2020-2025)
6.3 APAC Dog Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Dog Vaccines by Country
7.1.1 Europe Dog Vaccines Sales by Country (2020-2025)
7.1.2 Europe Dog Vaccines Revenue by Country (2020-2025)
7.2 Europe Dog Vaccines Sales by Type (2020-2025)
7.3 Europe Dog Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dog Vaccines by Country
8.1.1 Middle East & Africa Dog Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Dog Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Dog Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Dog Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dog Vaccines
10.3 Manufacturing Process Analysis of Dog Vaccines
10.4 Industry Chain Structure of Dog Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dog Vaccines Distributors
11.3 Dog Vaccines Customer
12 WORLD FORECAST REVIEW FOR DOG VACCINES BY GEOGRAPHIC REGION
12.1 Global Dog Vaccines Market Size Forecast by Region
12.1.1 Global Dog Vaccines Forecast by Region (2026-2031)
12.1.2 Global Dog Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Dog Vaccines Forecast by Type (2026-2031)
12.7 Global Dog Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer Healthcare
13.1.1 Bayer Healthcare Company Information
13.1.2 Bayer Healthcare Dog Vaccines Product Portfolios and Specifications
13.1.3 Bayer Healthcare Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer Healthcare Main Business Overview
13.1.5 Bayer Healthcare Latest Developments
13.2 Vetoquinol S.A
13.2.1 Vetoquinol S.A Company Information
13.2.2 Vetoquinol S.A Dog Vaccines Product Portfolios and Specifications
13.2.3 Vetoquinol S.A Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Vetoquinol S.A Main Business Overview
13.2.5 Vetoquinol S.A Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Dog Vaccines Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Dog Vaccines Product Portfolios and Specifications
13.4.3 Ceva Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 Eli Lilly
13.5.1 Eli Lilly Company Information
13.5.2 Eli Lilly Dog Vaccines Product Portfolios and Specifications
13.5.3 Eli Lilly Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Eli Lilly Main Business Overview
13.5.5 Eli Lilly Latest Developments
13.6 Heska Co.
13.6.1 Heska Co. Company Information
13.6.2 Heska Co. Dog Vaccines Product Portfolios and Specifications
13.6.3 Heska Co. Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Heska Co. Main Business Overview
13.6.5 Heska Co. Latest Developments
13.7 Merck Animal Health
13.7.1 Merck Animal Health Company Information
13.7.2 Merck Animal Health Dog Vaccines Product Portfolios and Specifications
13.7.3 Merck Animal Health Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Merck Animal Health Main Business Overview
13.7.5 Merck Animal Health Latest Developments
13.8 Merial (Sanofi)
13.8.1 Merial (Sanofi) Company Information
13.8.2 Merial (Sanofi) Dog Vaccines Product Portfolios and Specifications
13.8.3 Merial (Sanofi) Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Merial (Sanofi) Main Business Overview
13.8.5 Merial (Sanofi) Latest Developments
13.9 Virbac
13.9.1 Virbac Company Information
13.9.2 Virbac Dog Vaccines Product Portfolios and Specifications
13.9.3 Virbac Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Virbac Main Business Overview
13.9.5 Virbac Latest Developments
13.10 Zoetis (Pfizer)
13.10.1 Zoetis (Pfizer) Company Information
13.10.2 Zoetis (Pfizer) Dog Vaccines Product Portfolios and Specifications
13.10.3 Zoetis (Pfizer) Dog Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Zoetis (Pfizer) Main Business Overview
13.10.5 Zoetis (Pfizer) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Dog Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Dog Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Attenuated Live Vaccines
Table 4. Major Players of Conjugate Vaccines
Table 5. Major Players of Inactivated Vaccines
Table 6. Major Players of Subunit Vaccines
Table 7. Major Players of Toxoid Vaccines
Table 8. Major Players of DNA Vaccines
Table 9. Major Players of Recombinant Vaccines
Table 10. Global Dog Vaccines Sales by Type (2020-2025) & (K Doses)
Table 11. Global Dog Vaccines Sales Market Share by Type (2020-2025)
Table 12. Global Dog Vaccines Revenue by Type (2020-2025) & ($ million)
Table 13. Global Dog Vaccines Revenue Market Share by Type (2020-2025)
Table 14. Global Dog Vaccines Sale Price by Type (2020-2025) & (USD/Dose)
Table 15. Global Dog Vaccines Sale by Application (2020-2025) & (K Doses)
Table 16. Global Dog Vaccines Sale Market Share by Application (2020-2025)
Table 17. Global Dog Vaccines Revenue by Application (2020-2025) & ($ million)
Table 18. Global Dog Vaccines Revenue Market Share by Application (2020-2025)
Table 19. Global Dog Vaccines Sale Price by Application (2020-2025) & (USD/Dose)
Table 20. Global Dog Vaccines Sales by Company (2020-2025) & (K Doses)
Table 21. Global Dog Vaccines Sales Market Share by Company (2020-2025)
Table 22. Global Dog Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 23. Global Dog Vaccines Revenue Market Share by Company (2020-2025)
Table 24. Global Dog Vaccines Sale Price by Company (2020-2025) & (USD/Dose)
Table 25. Key Manufacturers Dog Vaccines Producing Area Distribution and Sales Area
Table 26. Players Dog Vaccines Products Offered
Table 27. Dog Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 28. New Products and Potential Entrants
Table 29. Market M&A Activity & Strategy
Table 30. Global Dog Vaccines Sales by Geographic Region (2020-2025) & (K Doses)
Table 31. Global Dog Vaccines Sales Market Share Geographic Region (2020-2025)
Table 32. Global Dog Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 33. Global Dog Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 34. Global Dog Vaccines Sales by Country/Region (2020-2025) & (K Doses)
Table 35. Global Dog Vaccines Sales Market Share by Country/Region (2020-2025)
Table 36. Global Dog Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 37. Global Dog Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 38. Americas Dog Vaccines Sales by Country (2020-2025) & (K Doses)
Table 39. Americas Dog Vaccines Sales Market Share by Country (2020-2025)
Table 40. Americas Dog Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 41. Americas Dog Vaccines Sales by Type (2020-2025) & (K Doses)
Table 42. Americas Dog Vaccines Sales by Application (2020-2025) & (K Doses)
Table 43. APAC Dog Vaccines Sales by Region (2020-2025) & (K Doses)
Table 44. APAC Dog Vaccines Sales Market Share by Region (2020-2025)
Table 45. APAC Dog Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 46. APAC Dog Vaccines Sales by Type (2020-2025) & (K Doses)
Table 47. APAC Dog Vaccines Sales by Application (2020-2025) & (K Doses)
Table 48. Europe Dog Vaccines Sales by Country (2020-2025) & (K Doses)
Table 49. Europe Dog Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 50. Europe Dog Vaccines Sales by Type (2020-2025) & (K Doses)
Table 51. Europe Dog Vaccines Sales by Application (2020-2025) & (K Doses)
Table 52. Middle East & Africa Dog Vaccines Sales by Country (2020-2025) & (K Doses)
Table 53. Middle East & Africa Dog Vaccines Revenue Market Share by Country (2020-2025)
Table 54. Middle East & Africa Dog Vaccines Sales by Type (2020-2025) & (K Doses)
Table 55. Middle East & Africa Dog Vaccines Sales by Application (2020-2025) & (K Doses)
Table 56. Key Market Drivers & Growth Opportunities of Dog Vaccines
Table 57. Key Market Challenges & Risks of Dog Vaccines
Table 58. Key Industry Trends of Dog Vaccines
Table 59. Dog Vaccines Raw Material
Table 60. Key Suppliers of Raw Materials
Table 61. Dog Vaccines Distributors List
Table 62. Dog Vaccines Customer List
Table 63. Global Dog Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 64. Global Dog Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Americas Dog Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 66. Americas Dog Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. APAC Dog Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 68. APAC Dog Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 69. Europe Dog Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 70. Europe Dog Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Middle East & Africa Dog Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 72. Middle East & Africa Dog Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 73. Global Dog Vaccines Sales Forecast by Type (2026-2031) & (K Doses)
Table 74. Global Dog Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 75. Global Dog Vaccines Sales Forecast by Application (2026-2031) & (K Doses)
Table 76. Global Dog Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 77. Bayer Healthcare Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. Bayer Healthcare Dog Vaccines Product Portfolios and Specifications
Table 79. Bayer Healthcare Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. Bayer Healthcare Main Business
Table 81. Bayer Healthcare Latest Developments
Table 82. Vetoquinol S.A Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. Vetoquinol S.A Dog Vaccines Product Portfolios and Specifications
Table 84. Vetoquinol S.A Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Vetoquinol S.A Main Business
Table 86. Vetoquinol S.A Latest Developments
Table 87. Boehringer Ingelheim Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Boehringer Ingelheim Dog Vaccines Product Portfolios and Specifications
Table 89. Boehringer Ingelheim Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Boehringer Ingelheim Main Business
Table 91. Boehringer Ingelheim Latest Developments
Table 92. Ceva Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Ceva Dog Vaccines Product Portfolios and Specifications
Table 94. Ceva Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Ceva Main Business
Table 96. Ceva Latest Developments
Table 97. Eli Lilly Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Eli Lilly Dog Vaccines Product Portfolios and Specifications
Table 99. Eli Lilly Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. Eli Lilly Main Business
Table 101. Eli Lilly Latest Developments
Table 102. Heska Co. Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Heska Co. Dog Vaccines Product Portfolios and Specifications
Table 104. Heska Co. Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. Heska Co. Main Business
Table 106. Heska Co. Latest Developments
Table 107. Merck Animal Health Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Merck Animal Health Dog Vaccines Product Portfolios and Specifications
Table 109. Merck Animal Health Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 110. Merck Animal Health Main Business
Table 111. Merck Animal Health Latest Developments
Table 112. Merial (Sanofi) Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Merial (Sanofi) Dog Vaccines Product Portfolios and Specifications
Table 114. Merial (Sanofi) Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 115. Merial (Sanofi) Main Business
Table 116. Merial (Sanofi) Latest Developments
Table 117. Virbac Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. Virbac Dog Vaccines Product Portfolios and Specifications
Table 119. Virbac Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 120. Virbac Main Business
Table 121. Virbac Latest Developments
Table 122. Zoetis (Pfizer) Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Zoetis (Pfizer) Dog Vaccines Product Portfolios and Specifications
Table 124. Zoetis (Pfizer) Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 125. Zoetis (Pfizer) Main Business
Table 126. Zoetis (Pfizer) Latest Developments
Table 1. Dog Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Dog Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Attenuated Live Vaccines
Table 4. Major Players of Conjugate Vaccines
Table 5. Major Players of Inactivated Vaccines
Table 6. Major Players of Subunit Vaccines
Table 7. Major Players of Toxoid Vaccines
Table 8. Major Players of DNA Vaccines
Table 9. Major Players of Recombinant Vaccines
Table 10. Global Dog Vaccines Sales by Type (2020-2025) & (K Doses)
Table 11. Global Dog Vaccines Sales Market Share by Type (2020-2025)
Table 12. Global Dog Vaccines Revenue by Type (2020-2025) & ($ million)
Table 13. Global Dog Vaccines Revenue Market Share by Type (2020-2025)
Table 14. Global Dog Vaccines Sale Price by Type (2020-2025) & (USD/Dose)
Table 15. Global Dog Vaccines Sale by Application (2020-2025) & (K Doses)
Table 16. Global Dog Vaccines Sale Market Share by Application (2020-2025)
Table 17. Global Dog Vaccines Revenue by Application (2020-2025) & ($ million)
Table 18. Global Dog Vaccines Revenue Market Share by Application (2020-2025)
Table 19. Global Dog Vaccines Sale Price by Application (2020-2025) & (USD/Dose)
Table 20. Global Dog Vaccines Sales by Company (2020-2025) & (K Doses)
Table 21. Global Dog Vaccines Sales Market Share by Company (2020-2025)
Table 22. Global Dog Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 23. Global Dog Vaccines Revenue Market Share by Company (2020-2025)
Table 24. Global Dog Vaccines Sale Price by Company (2020-2025) & (USD/Dose)
Table 25. Key Manufacturers Dog Vaccines Producing Area Distribution and Sales Area
Table 26. Players Dog Vaccines Products Offered
Table 27. Dog Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 28. New Products and Potential Entrants
Table 29. Market M&A Activity & Strategy
Table 30. Global Dog Vaccines Sales by Geographic Region (2020-2025) & (K Doses)
Table 31. Global Dog Vaccines Sales Market Share Geographic Region (2020-2025)
Table 32. Global Dog Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 33. Global Dog Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 34. Global Dog Vaccines Sales by Country/Region (2020-2025) & (K Doses)
Table 35. Global Dog Vaccines Sales Market Share by Country/Region (2020-2025)
Table 36. Global Dog Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 37. Global Dog Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 38. Americas Dog Vaccines Sales by Country (2020-2025) & (K Doses)
Table 39. Americas Dog Vaccines Sales Market Share by Country (2020-2025)
Table 40. Americas Dog Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 41. Americas Dog Vaccines Sales by Type (2020-2025) & (K Doses)
Table 42. Americas Dog Vaccines Sales by Application (2020-2025) & (K Doses)
Table 43. APAC Dog Vaccines Sales by Region (2020-2025) & (K Doses)
Table 44. APAC Dog Vaccines Sales Market Share by Region (2020-2025)
Table 45. APAC Dog Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 46. APAC Dog Vaccines Sales by Type (2020-2025) & (K Doses)
Table 47. APAC Dog Vaccines Sales by Application (2020-2025) & (K Doses)
Table 48. Europe Dog Vaccines Sales by Country (2020-2025) & (K Doses)
Table 49. Europe Dog Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 50. Europe Dog Vaccines Sales by Type (2020-2025) & (K Doses)
Table 51. Europe Dog Vaccines Sales by Application (2020-2025) & (K Doses)
Table 52. Middle East & Africa Dog Vaccines Sales by Country (2020-2025) & (K Doses)
Table 53. Middle East & Africa Dog Vaccines Revenue Market Share by Country (2020-2025)
Table 54. Middle East & Africa Dog Vaccines Sales by Type (2020-2025) & (K Doses)
Table 55. Middle East & Africa Dog Vaccines Sales by Application (2020-2025) & (K Doses)
Table 56. Key Market Drivers & Growth Opportunities of Dog Vaccines
Table 57. Key Market Challenges & Risks of Dog Vaccines
Table 58. Key Industry Trends of Dog Vaccines
Table 59. Dog Vaccines Raw Material
Table 60. Key Suppliers of Raw Materials
Table 61. Dog Vaccines Distributors List
Table 62. Dog Vaccines Customer List
Table 63. Global Dog Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 64. Global Dog Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Americas Dog Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 66. Americas Dog Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. APAC Dog Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 68. APAC Dog Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 69. Europe Dog Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 70. Europe Dog Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Middle East & Africa Dog Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 72. Middle East & Africa Dog Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 73. Global Dog Vaccines Sales Forecast by Type (2026-2031) & (K Doses)
Table 74. Global Dog Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 75. Global Dog Vaccines Sales Forecast by Application (2026-2031) & (K Doses)
Table 76. Global Dog Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 77. Bayer Healthcare Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. Bayer Healthcare Dog Vaccines Product Portfolios and Specifications
Table 79. Bayer Healthcare Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. Bayer Healthcare Main Business
Table 81. Bayer Healthcare Latest Developments
Table 82. Vetoquinol S.A Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. Vetoquinol S.A Dog Vaccines Product Portfolios and Specifications
Table 84. Vetoquinol S.A Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Vetoquinol S.A Main Business
Table 86. Vetoquinol S.A Latest Developments
Table 87. Boehringer Ingelheim Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Boehringer Ingelheim Dog Vaccines Product Portfolios and Specifications
Table 89. Boehringer Ingelheim Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Boehringer Ingelheim Main Business
Table 91. Boehringer Ingelheim Latest Developments
Table 92. Ceva Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Ceva Dog Vaccines Product Portfolios and Specifications
Table 94. Ceva Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Ceva Main Business
Table 96. Ceva Latest Developments
Table 97. Eli Lilly Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Eli Lilly Dog Vaccines Product Portfolios and Specifications
Table 99. Eli Lilly Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. Eli Lilly Main Business
Table 101. Eli Lilly Latest Developments
Table 102. Heska Co. Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Heska Co. Dog Vaccines Product Portfolios and Specifications
Table 104. Heska Co. Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. Heska Co. Main Business
Table 106. Heska Co. Latest Developments
Table 107. Merck Animal Health Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Merck Animal Health Dog Vaccines Product Portfolios and Specifications
Table 109. Merck Animal Health Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 110. Merck Animal Health Main Business
Table 111. Merck Animal Health Latest Developments
Table 112. Merial (Sanofi) Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Merial (Sanofi) Dog Vaccines Product Portfolios and Specifications
Table 114. Merial (Sanofi) Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 115. Merial (Sanofi) Main Business
Table 116. Merial (Sanofi) Latest Developments
Table 117. Virbac Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. Virbac Dog Vaccines Product Portfolios and Specifications
Table 119. Virbac Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 120. Virbac Main Business
Table 121. Virbac Latest Developments
Table 122. Zoetis (Pfizer) Basic Information, Dog Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Zoetis (Pfizer) Dog Vaccines Product Portfolios and Specifications
Table 124. Zoetis (Pfizer) Dog Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 125. Zoetis (Pfizer) Main Business
Table 126. Zoetis (Pfizer) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Dog Vaccines
Figure 2. Dog Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dog Vaccines Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Dog Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Dog Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Dog Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Dog Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Attenuated Live Vaccines
Figure 12. Product Picture of Conjugate Vaccines
Figure 13. Product Picture of Inactivated Vaccines
Figure 14. Product Picture of Subunit Vaccines
Figure 15. Product Picture of Toxoid Vaccines
Figure 16. Product Picture of DNA Vaccines
Figure 17. Product Picture of Recombinant Vaccines
Figure 18. Global Dog Vaccines Sales Market Share by Type in 2025
Figure 19. Global Dog Vaccines Revenue Market Share by Type (2020-2025)
Figure 20. Dog Vaccines Consumed in Below 6 Months
Figure 21. Global Dog Vaccines Market: Below 6 Months (2020-2025) & (K Doses)
Figure 22. Dog Vaccines Consumed in Above Months
Figure 23. Global Dog Vaccines Market: Above Months (2020-2025) & (K Doses)
Figure 24. Global Dog Vaccines Sale Market Share by Application (2024)
Figure 25. Global Dog Vaccines Revenue Market Share by Application in 2025
Figure 26. Dog Vaccines Sales by Company in 2025 (K Doses)
Figure 27. Global Dog Vaccines Sales Market Share by Company in 2025
Figure 28. Dog Vaccines Revenue by Company in 2025 ($ millions)
Figure 29. Global Dog Vaccines Revenue Market Share by Company in 2025
Figure 30. Global Dog Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Dog Vaccines Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Dog Vaccines Sales 2020-2025 (K Doses)
Figure 33. Americas Dog Vaccines Revenue 2020-2025 ($ millions)
Figure 34. APAC Dog Vaccines Sales 2020-2025 (K Doses)
Figure 35. APAC Dog Vaccines Revenue 2020-2025 ($ millions)
Figure 36. Europe Dog Vaccines Sales 2020-2025 (K Doses)
Figure 37. Europe Dog Vaccines Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Dog Vaccines Sales 2020-2025 (K Doses)
Figure 39. Middle East & Africa Dog Vaccines Revenue 2020-2025 ($ millions)
Figure 40. Americas Dog Vaccines Sales Market Share by Country in 2025
Figure 41. Americas Dog Vaccines Revenue Market Share by Country (2020-2025)
Figure 42. Americas Dog Vaccines Sales Market Share by Type (2020-2025)
Figure 43. Americas Dog Vaccines Sales Market Share by Application (2020-2025)
Figure 44. United States Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Dog Vaccines Sales Market Share by Region in 2025
Figure 49. APAC Dog Vaccines Revenue Market Share by Region (2020-2025)
Figure 50. APAC Dog Vaccines Sales Market Share by Type (2020-2025)
Figure 51. APAC Dog Vaccines Sales Market Share by Application (2020-2025)
Figure 52. China Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. India Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Dog Vaccines Sales Market Share by Country in 2025
Figure 60. Europe Dog Vaccines Revenue Market Share by Country (2020-2025)
Figure 61. Europe Dog Vaccines Sales Market Share by Type (2020-2025)
Figure 62. Europe Dog Vaccines Sales Market Share by Application (2020-2025)
Figure 63. Germany Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. France Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Dog Vaccines Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Dog Vaccines Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Dog Vaccines Sales Market Share by Application (2020-2025)
Figure 71. Egypt Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Dog Vaccines in 2025
Figure 77. Manufacturing Process Analysis of Dog Vaccines
Figure 78. Industry Chain Structure of Dog Vaccines
Figure 79. Channels of Distribution
Figure 80. Global Dog Vaccines Sales Market Forecast by Region (2026-2031)
Figure 81. Global Dog Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Dog Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Dog Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Dog Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Dog Vaccines Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Dog Vaccines
Figure 2. Dog Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dog Vaccines Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Dog Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Dog Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Dog Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Dog Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Attenuated Live Vaccines
Figure 12. Product Picture of Conjugate Vaccines
Figure 13. Product Picture of Inactivated Vaccines
Figure 14. Product Picture of Subunit Vaccines
Figure 15. Product Picture of Toxoid Vaccines
Figure 16. Product Picture of DNA Vaccines
Figure 17. Product Picture of Recombinant Vaccines
Figure 18. Global Dog Vaccines Sales Market Share by Type in 2025
Figure 19. Global Dog Vaccines Revenue Market Share by Type (2020-2025)
Figure 20. Dog Vaccines Consumed in Below 6 Months
Figure 21. Global Dog Vaccines Market: Below 6 Months (2020-2025) & (K Doses)
Figure 22. Dog Vaccines Consumed in Above Months
Figure 23. Global Dog Vaccines Market: Above Months (2020-2025) & (K Doses)
Figure 24. Global Dog Vaccines Sale Market Share by Application (2024)
Figure 25. Global Dog Vaccines Revenue Market Share by Application in 2025
Figure 26. Dog Vaccines Sales by Company in 2025 (K Doses)
Figure 27. Global Dog Vaccines Sales Market Share by Company in 2025
Figure 28. Dog Vaccines Revenue by Company in 2025 ($ millions)
Figure 29. Global Dog Vaccines Revenue Market Share by Company in 2025
Figure 30. Global Dog Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Dog Vaccines Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Dog Vaccines Sales 2020-2025 (K Doses)
Figure 33. Americas Dog Vaccines Revenue 2020-2025 ($ millions)
Figure 34. APAC Dog Vaccines Sales 2020-2025 (K Doses)
Figure 35. APAC Dog Vaccines Revenue 2020-2025 ($ millions)
Figure 36. Europe Dog Vaccines Sales 2020-2025 (K Doses)
Figure 37. Europe Dog Vaccines Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Dog Vaccines Sales 2020-2025 (K Doses)
Figure 39. Middle East & Africa Dog Vaccines Revenue 2020-2025 ($ millions)
Figure 40. Americas Dog Vaccines Sales Market Share by Country in 2025
Figure 41. Americas Dog Vaccines Revenue Market Share by Country (2020-2025)
Figure 42. Americas Dog Vaccines Sales Market Share by Type (2020-2025)
Figure 43. Americas Dog Vaccines Sales Market Share by Application (2020-2025)
Figure 44. United States Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Dog Vaccines Sales Market Share by Region in 2025
Figure 49. APAC Dog Vaccines Revenue Market Share by Region (2020-2025)
Figure 50. APAC Dog Vaccines Sales Market Share by Type (2020-2025)
Figure 51. APAC Dog Vaccines Sales Market Share by Application (2020-2025)
Figure 52. China Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. India Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Dog Vaccines Sales Market Share by Country in 2025
Figure 60. Europe Dog Vaccines Revenue Market Share by Country (2020-2025)
Figure 61. Europe Dog Vaccines Sales Market Share by Type (2020-2025)
Figure 62. Europe Dog Vaccines Sales Market Share by Application (2020-2025)
Figure 63. Germany Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. France Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Dog Vaccines Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Dog Vaccines Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Dog Vaccines Sales Market Share by Application (2020-2025)
Figure 71. Egypt Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Dog Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Dog Vaccines in 2025
Figure 77. Manufacturing Process Analysis of Dog Vaccines
Figure 78. Industry Chain Structure of Dog Vaccines
Figure 79. Channels of Distribution
Figure 80. Global Dog Vaccines Sales Market Forecast by Region (2026-2031)
Figure 81. Global Dog Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Dog Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Dog Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Dog Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Dog Vaccines Revenue Market Share Forecast by Application (2026-2031)
